A1
L-citrulline
- Product declaration
- L-Citrulline: 8 g
- Selected studied range
- 3000 to 9000 mg
- Protocol and duration
- per day, in the studies NIH ODS summarizes
- Studied context
- Studied as a nitric-oxide pathway precursor (converted to arginine via the urea cycle) for aerobic exercise performance measures such as oxygen-uptake (VO2) kinetics, blood lactate, and rate of perceived exertion, and for acute resistance-exercise performance and muscle oxygenation. NIH ODS describes evidence for enhancing performance as limited, with few studies and conflicting results.
- Limitations
- A 2022 systematic review/meta-analysis found no significant benefit for endurance-performance outcomes specifically. A single 8 g acute dose did not enhance isometric force production, muscle endurance, or muscle-oxygenation parameters in one resistance-exercise study. NIH ODS characterizes overall performance-enhancement evidence as limited.
Selected evidence: NIH ODS, Dietary Supplements for Exercise and Athletic Performance · Open source
A2
Beta-alanine
- Product declaration
- Beta Alanine: 3.2 g
- Selected studied range
- 4000 to 6000 mg
- Protocol and duration
- per day in divided doses, for at least 2 to 4 weeks, not as a single pre-workout dose
- Studied context
- Studied for high-intensity exercise capacity in the 60-240 second range via elevation of muscle carnosine, which acts as an intracellular pH buffer against acidosis. ISSN 2015 position stand: greatest performance benefits in "open end-point" tasks/time trials lasting 1-4 minutes; some benefit noted in aerobic exercise up to roughly 25 minutes; attenuation of neuromuscular fatigue, particularly noted in older adults.
- Limitations
- Strength/resistance-training outcomes remain mixed; training volume may increase without a clear strength gain. Tasks under 60 seconds do not show benefit. Endurance benefit beyond about 25 minutes is not established. Long-term safety data beyond roughly a year, and effects in special/tactical populations, are flagged as needing more research.
Selected evidence: ISSN position stand on beta-alanine, 2015 · Open source
A1
Betaine anhydrous
- Product declaration
- Betaine Anhydrous: 2 g
- Selected studied range
- 2000 to 5000 mg
- Protocol and duration
- per day, studied for up to 15 days
- Studied context
- NIH ODS describes betaine as studied for strength- and power-based performance in bodybuilders and cyclists, with "potential but modest" improvements from a limited set of small, sometimes conflicting studies. A 2024/2025 systematic review focused specifically on endurance performance (VO2max, time-to-exhaustion, time-to-completion, power output).
- Limitations
- The endurance systematic review explicitly states "limited and inconclusive evidence regarding the definitive ergogenic effect of betaine supplementation on endurance exercise performance". Only 2 of 5 reviewed studies showed a significant improvement, and the authors call for "additional, more rigorous research."
Selected evidence: NIH ODS, Dietary Supplements for Exercise and Athletic Performance · Open source
A2
L-tyrosine
- Product declaration
- L-Tyrosine: 2 g
- Selected studied range
- 2000 to 2000 mg
- Protocol and duration
- per day for five days, in the cadet study
- Studied context
- Studied as the dietary precursor to norepinephrine for mitigating cognitive performance decrements under acute stress. A 2015 Military Medicine evidence review (rapid evidence assessment, 14 trials: 10 RCTs + 4 controlled clinical trials) issued a "weak recommendation" in favor of tyrosine for cognitive stress specifically, stating "all studies showed a positive effect" on that outcome. A widely cited primary study (Deijen et al. 1999, Brain Research Bulletin) gave cadets 2 g tyrosine daily for five days during a combat training course and found better memory and tracking-task performance, plus lower systolic blood pressure, versus a carbohydrate control.
- Limitations
- The 2015 Military Medicine review states explicitly that "no recommendation could be made" for tyrosine's effect on physical performance under stressful physical conditions, and concludes "available evidence is insufficient to make confident recommendations on the effectiveness of tyrosine for mitigating stress effects on physical/cognitive performance" overall, despite the positive signal on cognition. A separate heat-stress study found tyrosine ingestion did not influence cognitive function or physical performance during exercise heat stress despite raised serum tyrosine. NIH ODS's exercise/athletic-performance fact sheet does not cover tyrosine at all.
Selected evidence: Deijen et al., Brain Research Bulletin, 1999
A2
Taurine
- Product declaration
- Taurine: 1 g
- Selected studied range
- 1000 to 3000 mg
- Protocol and duration
- per day, acutely across 6 to 15 days
- Studied context
- Studied for aerobic performance (VO2max, time-to-exhaustion, time-trial performance), anaerobic/strength performance, exercise-induced muscle damage, and recovery. A 2018 review ("Taurine in sports and exercise," PMC8152067) reports small-to-moderate improvements across several of these outcomes in some studies.
- Limitations
- The 2018 review states plainly: "limited and varied findings prohibit definitive conclusions regarding the efficacy of taurine on aerobic and anaerobic performance," and separately notes no peer-reviewed evidence exists for an independent role of taurine in skeletal-muscle hypertrophy.
Selected evidence: Taurine in sports and exercise, 2018 · Open source
A2
Agmatine sulfate
- Product declaration
- AGmass® (Agmatine Sulfate): 500 mg
- Selected studied range
- No dose range selected
- Protocol and duration
- Not recorded in the selected comparison
- Studied context
- Human data is comparatively sparse. A randomized double-blind placebo-controlled trial studied oral agmatine sulfate (1,335-3,560 mg/day for up to 3 weeks) for lumbar disc-associated radiculopathy (a clinical/pain context, not sports performance). A 2019 Scientific Reports paper examined safety and neurochemical profiles of acute and sub-chronic oral agmatine sulfate treatment.
- Limitations
- Sports-performance-specific human efficacy data for agmatine sulfate (e.g., a dedicated ISSN position stand) was not located in this research pass. Evidence located centers on safety/tolerability and non-sports clinical contexts rather than an authoritative performance-outcome verdict. Long-term safety in larger populations remains an open gap per the safety literature reviewed.
Selected evidence: Safety and neurochemical profiles of oral agmatine sulfate, 2019 · Open source
